Bannister J P, Young B A, Main M J, Sivaprasadarao A, Wray D
School of Biomedical Sciences, University of Leeds, UK.
Pflugers Arch. 1999 Nov;438(6):868-78. doi: 10.1007/s004249900126.
The inwardly rectifying potassium channel Kir2.3 possesses extracellular cysteine residues at positions 113, 140, and 145, as well as at position 79 near the outer membrane boundary. In this study, we have investigated the roles of these extracellular cysteine residues in mediating inhibition of the Kir2.3 channel by the cysteine-reactive reagents para-chloromercuribenzenesulphonate (PCMBS) and thimerosal, and the oxidizing agent hydrogen peroxide (H2O2). We have also compared the effects of these reagents with those on Kir1.1 channels (which do not possess cysteine residues equivalent to 140 and 79 in Kir2.3 channels). Mutant channels were made in which cysteine residues were mutated to serine by site-directed mutagenesis. Wild-type or mutant cRNA was injected into Xenopus oocytes and voltage-clamp recordings made 1-2 days later. Wild-type Kir2.3 currents were significantly inhibited by PCMBS, thimerosal and H2O2. Currents for mutants Kir2.3 C79S and C140S were also inhibited by PCMBS, thimerosal and H2O2. These mutations affected the time course of inhibition by all three reagents. For PCMBS, a slow component of inhibition was absent for the C79S mutation, and a fast component was absent for C140S. For the double mutation C79S/C140S, PCMBS no longer had any effect. For thimerosal, there was a slower time course for C140S, a faster time course for C79S, and a delayed onset for C79S/C140S. For H2O2, the main effect was a delayed onset for the double mutant. The reducing agent dithiothreitol (DTT) reversed the inhibition by both PCMBS and thimerosal of wild-type and mutant currents, but not the inhibition due to H2O2. Finally, wild-type Kir1.1 currents were not significantly inhibited by the applications of either PCMBS or thimerosal, while H2O2 produced small inhibition. The results taken together indicate that inhibition by the cysteine-reactive reagent PCMBS is mediated through cysteine residues 79 and 140 in Kir2.3 channels, with C79 mediating a slow component of inhibition and C140 a faster component, and that both residues are extracellularly exposed. The data indicate that these two cysteine residues are also main sites for inhibition by thimerosal and H2O2 but, unlike for PCMBS, an additional non-extracellular inhibitory site(s) must also be involved.
内向整流钾通道Kir2.3在第113、140和145位以及靠近外膜边界的第79位具有细胞外半胱氨酸残基。在本研究中,我们研究了这些细胞外半胱氨酸残基在介导半胱氨酸反应试剂对氯汞苯磺酸盐(PCMBS)、硫柳汞以及氧化剂过氧化氢(H2O2)抑制Kir2.3通道中的作用。我们还比较了这些试剂对Kir2.3通道的作用与对Kir1.1通道(其不具有与Kir2.3通道中第140和79位等效的半胱氨酸残基)的作用。通过定点诱变构建了将半胱氨酸残基突变为丝氨酸的突变通道。将野生型或突变型cRNA注射到非洲爪蟾卵母细胞中,1 - 2天后进行电压钳记录。野生型Kir2.3电流受到PCMBS、硫柳汞和H2O2的显著抑制。突变体Kir2.3 C79S和C140S的电流也受到PCMBS、硫柳汞和H2O2的抑制。这些突变影响了所有三种试剂的抑制时间进程。对于PCMBS,C79S突变不存在缓慢抑制成分,C140S突变不存在快速抑制成分。对于双突变C79S/C140S,PCMBS不再有任何作用。对于硫柳汞,C140S的时间进程较慢,C79S的时间进程较快,C79S/C140S的起效延迟。对于H2O2,主要影响是双突变体的起效延迟。还原剂二硫苏糖醇(DTT)可逆转PCMBS和硫柳汞对野生型和突变型电流的抑制,但不能逆转H2O2引起的抑制。最后,野生型Kir1.1电流在应用PCMBS或硫柳汞时未受到显著抑制,而H2O2产生较小抑制。综合结果表明,半胱氨酸反应试剂PCMBS的抑制作用是通过Kir2.3通道中的半胱氨酸残基79和140介导的,其中C79介导缓慢抑制成分,C140介导快速抑制成分,并且这两个残基都暴露于细胞外。数据表明这两个半胱氨酸残基也是硫柳汞和H2O2抑制的主要位点,但与PCMBS不同,还必须涉及一个额外的非细胞外抑制位点。